アルツハイマー病による薬物による死亡に関するプリプリントは,著者間の論争を引き起こした
まとめ
レカネマブによる死亡に関する予備的なデータは,最近の論文で述べられた主張を支持しません. 薬の安全性プロファイルと潜在的なリスクを明らかにするためにさらなる調査が必要である.
科学分野:
- 神経科学
- 薬理学について
- 臨床試験
背景:
- レカネマブは,アルツハイマー病に対するアミロイド標的療法です.
- 薬の安全性,特に潜在的致死性について懸念が提起されている.
- 最近の論文で,これらの死者についての主張がなされています.
関連する概念動画
Long-term Depression
30.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.6K
The Blood-brain Barrier
46.8K
Overview
46.8K
X-Inactivation
38.1K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
38.1K
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Altruism
40.9K
Altruistic behaviors are “unselfish” behaviors—those that help another individual at the expense of the individual carrying out the behavior. Despite the negative consequences for the altruistic animal, these behaviors are thought to have evolved for several reasons.
40.9K
Allosteric Regulation
57.7K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.7K


